174 related articles for article (PubMed ID: 25367979)
1. Prevention of skin carcinogenesis by the β-blocker carvedilol.
Chang A; Yeung S; Thakkar A; Huang KM; Liu MM; Kanassatega RS; Parsa C; Orlando R; Jackson EK; Andresen BT; Huang Y
Cancer Prev Res (Phila); 2015 Jan; 8(1):27-36. PubMed ID: 25367979
[TBL] [Abstract][Full Text] [Related]
2. Topically Applied Carvedilol Attenuates Solar Ultraviolet Radiation Induced Skin Carcinogenesis.
Huang KM; Liang S; Yeung S; Oiyemhonlan E; Cleveland KH; Parsa C; Orlando R; Meyskens FL; Andresen BT; Huang Y
Cancer Prev Res (Phila); 2017 Oct; 10(10):598-606. PubMed ID: 28912118
[TBL] [Abstract][Full Text] [Related]
3. Carvedilol inhibits EGF-mediated JB6 P+ colony formation through a mechanism independent of adrenoceptors.
Cleveland KH; Liang S; Chang A; Huang KM; Chen S; Guo L; Huang Y; Andresen BT
PLoS One; 2019; 14(5):e0217038. PubMed ID: 31107911
[TBL] [Abstract][Full Text] [Related]
4. Phosphoproteome profiling provides insight into the mechanism of action for carvedilol-mediated cancer prevention.
Cleveland KH; Yeung S; Huang KM; Liang S; Andresen BT; Huang Y
Mol Carcinog; 2018 Aug; 57(8):997-1007. PubMed ID: 29626349
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Neoplastic Transformation and Chemically-Induced Skin Hyperplasia in Mice by Traditional Chinese Medicinal Formula Si-Wu-Tang.
Liu MM; Huang KM; Yeung S; Chang A; Zhang S; Mei N; Parsa C; Orlando R; Huang Y
Nutrients; 2017 Mar; 9(3):. PubMed ID: 28335476
[TBL] [Abstract][Full Text] [Related]
6. The β-blocker Nebivolol Is a GRK/β-arrestin biased agonist.
Erickson CE; Gul R; Blessing CP; Nguyen J; Liu T; Pulakat L; Bastepe M; Jackson EK; Andresen BT
PLoS One; 2013; 8(8):e71980. PubMed ID: 23977191
[TBL] [Abstract][Full Text] [Related]
7. β-arrestin-biased signaling through the β2-adrenergic receptor promotes cardiomyocyte contraction.
Carr R; Schilling J; Song J; Carter RL; Du Y; Yoo SM; Traynham CJ; Koch WJ; Cheung JY; Tilley DG; Benovic JL
Proc Natl Acad Sci U S A; 2016 Jul; 113(28):E4107-16. PubMed ID: 27354517
[TBL] [Abstract][Full Text] [Related]
8. Prevention of Skin Carcinogenesis by the Non-β-blocking R-carvedilol Enantiomer.
Liang S; Shamim MA; Shahid A; Chen M; Cleveland KH; Parsa C; Orlando R; Andresen BT; Huang Y
Cancer Prev Res (Phila); 2021 May; 14(5):527-540. PubMed ID: 33648941
[TBL] [Abstract][Full Text] [Related]
9. Pro/antioxidant status and AP-1 transcription factor in murine skin following topical exposure to cumene hydroperoxide.
Murray AR; Kisin ER; Kommineni C; Vallyathan V; Castranova V; Shvedova AA
Carcinogenesis; 2007 Jul; 28(7):1582-8. PubMed ID: 17234724
[TBL] [Abstract][Full Text] [Related]
10. Carvedilol selectively inhibits oscillatory intracellular calcium changes evoked by human alpha1D- and alpha1B-adrenergic receptors.
Koshimizu TA; Tsujimoto G; Hirasawa A; Kitagawa Y; Tanoue A
Cardiovasc Res; 2004 Sep; 63(4):662-72. PubMed ID: 15306222
[TBL] [Abstract][Full Text] [Related]
11. Comparison between a sustained administration of carvedilol versus atenolol to reduce restenosis after coronary stenting.
Cha KS; Kim MH; Kim JW; Kim DI; Kim HJ; Kim DS; Kim JS
Am Heart J; 2004 Feb; 147(2):E7. PubMed ID: 14760341
[TBL] [Abstract][Full Text] [Related]
12. Carvedilol binding to β2-adrenergic receptors inhibits CFTR-dependent anion secretion in airway epithelial cells.
Peitzman ER; Zaidman NA; Maniak PJ; O'Grady SM
Am J Physiol Lung Cell Mol Physiol; 2016 Jan; 310(1):L50-8. PubMed ID: 26566905
[TBL] [Abstract][Full Text] [Related]
13. Comparative effectiveness of beta-adrenergic antagonists (atenolol, metoprolol tartrate, carvedilol) on the risk of rehospitalization in adults with heart failure.
Go AS; Yang J; Gurwitz JH; Hsu J; Lane K; Platt R
Am J Cardiol; 2007 Aug; 100(4):690-6. PubMed ID: 17697830
[TBL] [Abstract][Full Text] [Related]
14. Antiproliferative effects of β-blockers on human colorectal cancer cells.
Coelho M; Moz M; Correia G; Teixeira A; Medeiros R; Ribeiro L
Oncol Rep; 2015 May; 33(5):2513-20. PubMed ID: 25812650
[TBL] [Abstract][Full Text] [Related]
15. Peracetylated (-)-epigallocatechin-3-gallate (AcEGCG) potently prevents skin carcinogenesis by suppressing the PKD1-dependent signaling pathway in CD34+ skin stem cells and skin tumors.
Chiou YS; Sang S; Cheng KH; Ho CT; Wang YJ; Pan MH
Carcinogenesis; 2013 Jun; 34(6):1315-22. PubMed ID: 23385063
[TBL] [Abstract][Full Text] [Related]
16. Reduced expression of endothelial connexins 43 and 37 in hypertensive rats is rectified after 7-day carvedilol treatment.
Yeh HI; Lee PY; Su CH; Tian TY; Ko YS; Tsai CH
Am J Hypertens; 2006 Feb; 19(2):129-35. PubMed ID: 16448880
[TBL] [Abstract][Full Text] [Related]
17. Carvedilol but not metoprolol reduces beta-adrenergic responsiveness after complete elimination from plasma in vivo.
Kindermann M; Maack C; Schaller S; Finkler N; Schmidt KI; Läer S; Wuttke H; Schäfers HJ; Böhm M
Circulation; 2004 Jun; 109(25):3182-90. PubMed ID: 15184276
[TBL] [Abstract][Full Text] [Related]
18. Synergistic effects of combined phytochemicals and skin cancer prevention in SENCAR mice.
Kowalczyk MC; Kowalczyk P; Tolstykh O; Hanausek M; Walaszek Z; Slaga TJ
Cancer Prev Res (Phila); 2010 Feb; 3(2):170-8. PubMed ID: 20103723
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of carvedilol in mild to moderate essential hypertension and effects on microalbuminuria: a multicenter, randomized, open-label, controlled study versus atenolol.
Marchi F; Ciriello G
Adv Ther; 1995; 12(4):212-21. PubMed ID: 10155349
[TBL] [Abstract][Full Text] [Related]
20. Modulation of biomarkers related to tumor initiation and promotion in mouse skin by a natural β-glucuronidase inhibitor and its precursors.
Kowalczyk MC; Spears E; Narog M; Zoltaszek R; Kowalczyk P; Hanausek M; Yoshimi N; Slaga TJ; Walaszek Z
Oncol Rep; 2011 Sep; 26(3):551-6. PubMed ID: 21687956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
